Transcriptomics

Dataset Information

0

Drug synergy slows ageing and improves healthspan through IGF and SREBP lipid signaling


ABSTRACT: Pharmacological interventions directly modulating ageing would extend human healthspan, resulting in dramatic medical and economic benefits. Such interventions should be efficacious in adults and ideally repurpose drugs known to be safe. Here we show that dramatic lifespan extension can be achieved by targeting multiple, evolutionarily conserved ageing pathways using drugs already used in humans. Using this approach in C. elegans, we were able to slow ageing, improve healthspan and minimize trade-offs. We show that daf-2, daf-7 and sbp-1 (mammalian SREBP-1c) interact upstream of changes in lipid metabolism, resulting in increased monounsaturated fatty acid content and lifespan extension. For one combination, we observed evolutionary conservation in fruit flies. To the best of our knowledge, this is the largest lifespan effect ever reported for any adult-onset drug treatment in C. elegans. Drug repurposing approaches, by leveraging drugs already approved for humans, could lead to rapid translation of experimental results to clinical applications.

ORGANISM(S): Caenorhabditis elegans

PROVIDER: GSE108263 | GEO | 2018/12/17

REPOSITORIES: GEO

Similar Datasets

2021-07-06 | GSE149944 | GEO
2022-12-29 | GSE150108 | GEO
2021-03-06 | GSE168322 | GEO
2022-09-27 | GSE178816 | GEO
2016-09-27 | PXD002317 | Pride
2018-08-27 | GSE117188 | GEO
2018-12-15 | GSE123862 | GEO
2018-02-26 | GSE93724 | GEO
2010-05-16 | E-GEOD-18563 | biostudies-arrayexpress
2018-12-01 | GSE123163 | GEO